Quarterly report pursuant to Section 13 or 15(d)

ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.21.2
ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
May 21, 2020
Mar. 23, 2020
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Research and development costs     $ 314,532 $ 89,570 $ 485,995 $ 157,280  
Impairment loss         39,434 25,320,555  
Loss from operation     (1,314,688) $ (26,049,904) (2,281,702) (26,479,237) $ (25,359,989)
Advertising and marketing costs         $ 59,500 $ 34,973  
Valuation allowance, percentage         100.00%   100.00%
FDIC insured limit     $ 250,000   $ 250,000    
Ownership interest, percentage     1.38%   1.38%   1.38%
Common stock, shares authorized     100,000,000   100,000,000   100,000,000
Common stock, par value     $ 0.00001   $ 0.00001   $ 0.00001
Annual Meeting of Shareholders [Member]              
Common stock, shares authorized   100,000,000 800,000,000   800,000,000    
Common stock, par value   $ 0.00001 $ 0.00001   $ 0.00001    
Description of reverse stock split The effective dates of the above actions were June 5, 2020 and April 20, 2020, respectively, and the actual reverse stock split ratio was 1-for-33.26 Reverse stock split of the Company’s outstanding common stock at a ratio between 1-for-32 and 1-for-35 (with the exact ratio to be determined by the directors in their sole discretion without further approval by the shareholders).